Boston Scientific announces results for first quarter 2026
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Boston Scientific (BSX) Tops Q1 EPS by 1c, Beats on Revenue; Offers FY26 EPS Guidance
April 22, 2026 6:31 AM EDTBoston Scientific (NYSE: BSX) reported Q1 EPS of $0.80, $0.01 better than the analyst estimate of $0.79. Revenue for the quarter came in at $5.2 billion versus the consensus estimate of $5.17 billion.
GUIDANCE:
Boston Scientific sees FY2026 EPS of $3.34-$3.41, versus the consensus of... More
